tiprankstipranks
Trending News
More News >
Unicycive Therapeutics (UNCY)
NASDAQ:UNCY
US Market

Unicycive Therapeutics (UNCY) Financial Statements

Compare
566 Followers

Unicycive Therapeutics Financial Overview

Unicycive Therapeutics's market cap is currently $90.99M. The company's EPS TTM is $-0.05; its P/E ratio is ―; Unicycive Therapeutics is scheduled to report earnings on May 14, 2025, and the estimated EPS forecast is $-0.07. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 675.00K$ 951.00K$ 0.00$ 0.00
Gross Profit$ 0.00$ 675.00K$ 944.00K$ -1.00K$ 0.00
Operating Income$ -32.12M$ -20.77M$ -18.05M$ -8.98M$ -2.02M
EBITDA$ -36.23M$ -30.18M$ -18.05M$ -8.98M$ 0.00
Net Income$ -36.73M$ -30.54M$ -18.06M$ -10.63M$ -2.51M
Balance Sheet
Cash & Short-Term Investments$ 26.14M$ 9.70M$ 455.00K$ 16.58M$ 0.00
Total Assets$ 31.67M$ 14.19M$ 2.82M$ 18.74M$ 204.00K
Total Debt$ 773.00K$ 811.00K$ 155.00K$ 306.00K$ 2.51M
Net Debt$ -25.37M$ -8.89M$ -300.00K$ -16.27M$ 2.51M
Total Liabilities$ 24.24M$ 18.00M$ 3.28M$ 2.26M$ 2.88M
Stockholders' Equity$ 7.43M$ -3.81M$ -466.00K$ 16.48M$ -2.67M
Cash Flow
Free Cash Flow$ -28.65M$ -18.30M$ -15.65M$ -5.80M$ -1.46M
Operating Cash Flow$ -28.57M$ -18.28M$ -15.65M$ -5.77M$ -1.46M
Investing Cash Flow$ -72.00K$ -12.00K$ -2.00K$ -29.00K$ 0.00
Financing Cash Flow$ 45.09M$ 27.54M$ -471.00K$ 22.38M$ 1.44M
Currency in USD

Unicycive Therapeutics Earnings and Revenue History

Unicycive Therapeutics Debt to Assets

Unicycive Therapeutics Cash Flow

Unicycive Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis